Getting advanced medical devices to children has long been a challenge for device companies. Economic considerations are at the heart of the issue; while pediatric devices are expensive to develop, the population that will ultimately benefit from them is small. As a result, clinicians must either improvise with adult technology or choose from a short list of aging devices cleared for pediatric indications.
But that may be changing, a senior US Food and Drug Administration official said at the recent Cardiovascular Research Technologies...